A retrospective study on newly diagnosed Hansen’s disease and its spectrum in a tertiary care hospital
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20231297Keywords:
Leprosy, M. leprae, Active case detection, Health services, Multi drug therapyAbstract
Background: Leprosy, a well known ancient disease caused by the pathogen Mycobacterium leprae. Leprosy became curable with the introduction of multi drug therapy (MDT). But the burden of the disease still continues to make an impact in the present society. India is one of the major contributors to the global leprosy case load even after elimination. The main aim of this study was to assess the clinical pattern of newly diagnosed leprosy patients and to emphasize the need of timely intervention.
Methods: This was a hospital based retrospective observational study. The medical records of all the newly diagnosed leprosy patients during the period of January 2022 to December 2022 were collected and various clinical and demographic factors were analyzed.
Results: Total 139 newly diagnosed leprosy cases were reported. The most common age group affected was 45-60 years. Males were predominantly affected than females. 128 cases were multibacillary leprosy and 11 were paucibacillary. Borderline tuberculoid (48.2%) was the most common spectrum noted. About 19.4% patients presented with lepra reactions and 25.17% patients presented with deformities.
Conclusions: Newly diagnosed leprosy cases show that leprosy is active in the society. Active case detection by household contact survey and timely referral &treatment initiation and follow up by the field staff of health facility will prevent disability and stigma.
References
Vashisht D, Shankar P, Pathania V, Sharma S, Sandhu S, Venugopal R. A retrospective clinico-epidemiological study of leprosy cases treated at a tertiary care hospital in Western Maharashtra. Med J DY Patil Vidyapeeth 2021;14:385-91.
Patil AA, Sherkhane MS. Clinico-epidemiological study of Hansen’s disease patients attending a tertiary care centre in South India. Int J Community Med Public Health. 2016;3(11):3092-5.
Blok DJ, Vlas SJD. Guiding policy towards zero leprosy: challenges for modelling & economic evaluation. Indian J Med Res. 2022;155(1):7-10.
NLEP Annual Report 2020-2021. Central Leprosy Division, Directorate General of Health Services, Ministry of Health and Family Welfare Government of India. Nirman Bhavan, New Delhi. Available at https://main.mohfw.gov.in. Accessed on 3 March 2023.
Adil M, Amin SS, Mohtashim M, Mushtaq S, Alam M, Priya A. Clinico-epidemiological study of leprosy from a North Indian tertiary care hospital. Int J Res Dermatol. 2018;4(4):518-21.
Sirisha NL, Sangem S, Kumar AS, Pavani N, Kumar S. Clinico epidemiological study of hansens disease (leprosy) in patients attending government general hospital, Kadapa. Indian J Appl Res. 2019;9(12):9-11.
Narasimha RTV, Talluri A. Clinico-epidemiological study of childhood leprosy in post elimination period at a tertiary care hospital. Int J Contemp Med Res. 2019;6(12):1-3.
Vinnarasan M, Vinothiney K, Gopalan B. A clinico-epidemiological study of paediatric leprosy in a tertiary care centre. J. Evolution Med Dent Sci. 2018;7(21):2558-61.
Gupta R, Sinha R, Pradhan S. Clinico-epidemiological profile of leprosy in post elimination era: a hospital based study. Indian J Lepr. 2019;91:197-205.
Raffe SF, Thapa M, Khadge S, Tamang K, Hagge D. Diagnosis and treatment of leprosy reactions in integrated services-the patients’ perspective in Nepal. PLoS Negl Trop Dis. 2013;7(3):2089.
Kumar U, Varma K, Baraithiya K. Clinico-epidemiological and histopathological study of newly diagnosed leprosy patients at tertiary care center. IP Indian J Clin Exp Dermatol. 2020;6(4):374-81.
Rathod S, Suneetha S, Narang T, Bhardwaj A, Gupta SK, Kamoji SG, et al. Management of leprosy in the context of COVID 19 pandemic: Recommendations by SIG leprosy (IADVL academy). Indian Dermatol Online J. 2020;11:345-8.
